Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT06123338
Conditions
Esophageal Cancer
Gastric Adenocarcinoma
HER2 Gene Mutation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Trastuzumab
Oxaliplatin
Capecitabine
5-Fluorouracil
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-12. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-08-05.